France vs World: Access to anti-retroviral drugs, male
France
89.0%
in 2022
World
73.0%
in 2024
France rank
17th
World rank
15th
Access to anti-retroviral drugs, male over time
- France
- World
How they compare
France currently reports 89.0% against 73.0% in World, a difference of 16.0%.
That makes France's figure about 1.2 times World's.
Across all 23 years both countries report, France has been ahead every year.
France ranks 17th and World ranks 15th of 141 countries.
France has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | France | World | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 79.8% | 7.1% | 72.7% | France |
| 2010s | 86.9% | 40.6% | 46.3% | France |
| 2020s | 88.7% | 65.0% | 23.7% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, France or World?
- France, at 89.0% against 73.0% in World as of 2022.
- What is the difference in access to anti-retroviral drugs, male between France and World?
- 16.0%, with France ahead.
- How many years of comparable data are there for France and World?
- 23 years are reported by both, from 2000 to 2022.
- How do France and World rank globally for access to anti-retroviral drugs, male?
- France ranks 17th and World ranks 15th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.